FDA Inspection 1312270 — South Florida Institute For Reproductive Medicine
The FDA completed an inspection of South Florida Institute For Reproductive Medicine on Apr 6, 2026 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 6, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Naples, FL (United States)